Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 29 entries
View as:

Early Detection of Aortic Stenosis in the Community During Flu Vaccination

Phase: N/A Priority: Normal
NCT ID: NCT03250806 Org: User:
Start: 09/11/17 End: 11/30/17 Due: 11/30/18

Effects of Empagliflozin + Linagliptin vs Metformin + Insulin Glargine on Renal and Vascular Changes in Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT02752113 Org: User:
Start: 04/30/16 End: 05/31/19 Due: 05/31/20

Feasibility And Safety of Early Discharge After Transfemoral Transcatheter Aortic Valve Implantation

Phase: N/A Priority: Normal
NCT ID: NCT02404467 Org: User:
Start: 01/31/15 End: 07/31/19 Due: 07/31/20

Prospective Arm of Conduct - Edwards SAPIEN3 PPI Registry

Phase: N/A Priority: Normal
NCT ID: NCT03715894 Org: User:
Start: 12/01/18 End: 03/30/23 Due: 03/30/24

Pulmonic SAPIEN S3™ THV Registry

Phase: N/A Priority: Normal
NCT ID: NCT02777892 Org: User:
Start: 03/31/16 End: 07/31/23 Due: 07/31/24

Quality of Care in AS IMPULSE Study

Phase: N/A Priority: Normal
NCT ID: NCT02241447 Org: User:
Start: 08/08/14 End: 05/31/18 Due: 05/31/19

Operative Mitral Valve Reconstruction in Functional mv Insufficiency With Reduced Systolic Ventricle Function

Phase: N/A Priority: Normal
NCT ID: NCT03470155 Org: User:
Start: 06/05/18 End: 07/31/23 Due: 07/31/24

Validation of the "TASQ" in Patients Undergoing SAVR or TF-TAVI

Phase: N/A Priority: Normal
NCT ID: NCT03186339 Org: User:
Start: 09/08/17 End: 01/13/20 Due: 01/13/21

Single-Dose Bioavailability Study of Two Formulations of Ibuprofen and Pseudoephedrine Hydrochloride Tablets

Phase: N/A Priority: Normal
NCT ID: NCT03429738 Org: User:
Start: 04/27/14 End: 05/05/14 Due: 05/05/15

Edwards SAPIEN 3 PPI Registry

Phase: N/A Priority: Normal
NCT ID: NCT03497611 Org: User:
Start: 04/30/18 End: 03/03/19 Due: 03/03/20

Registry to Evaluate the Impact of a Valve Coordinator on Aortic Stenosis / TAVI Outcome - (German Pilot)

Phase: N/A Priority: Normal
NCT ID: NCT03570190 Org: User:
Start: 12/20/18 End: 12/19/19 Due: 12/19/20

Pulmonic SAPIEN XT THV

Phase: N/A Priority: Normal
NCT ID: NCT02302131 Org: User:
Start: 11/30/14 End: 04/30/17 Due: 04/30/18

Balloon Expandable Transcatheter Aortic Valve Implantation Without Predilation of the Aortic Valve

Phase: N/A Priority: Normal
NCT ID: NCT02127580 Org: User:
Start: 04/30/14 End: 05/31/16 Due: 05/31/17

ROUTE Registry Of the Utilisation of the Transaortic (Tao) TAVI Approach Using the Edwards Sapien XT Valve

Phase: N/A Priority: Normal
NCT ID: NCT01991431 Org: User:
Start: 02/28/13 End: 11/30/16 Due: 11/30/17

Sevicontrol-1: Efficacy and Safety of a Fixed Combination of Olmesartan/ Amlodipine

Phase: N/A Priority: Normal
NCT ID: NCT01613209 Org: User:
Start: 12/31/11 End: 10/31/12 Due: 10/31/13

Efficacy and Safety of a Therapy Change From Candesartan 32 mg to Fixed Combination of Olmesartan 40 mg/Amlodipine 10 mg

Phase: N/A Priority: Normal
NCT ID: NCT01611077 Org: User:
Start: 01/31/12 End: 01/31/13 Due: 01/31/14

Prospective, Long-term Evaluation of the SAPIEN 3 Ultra RESILIA Valve

Phase: N/A Priority: Normal
NCT ID: NCT06953206 Org: User:
Start: 06/01/25 End: 09/30/37 Due: 09/30/38

Optimizing Clinical Outcomes in Patients Undergoing Mitral Transcatheter Edge-to-edge Repair (M-TEER) for Severe Functional Mitral Regurgitation Towards Improved Guideline-directed Medical Therapy

Phase: N/A Priority: Normal
NCT ID: NCT06702527 Org: User:
Start: 06/01/25 End: 09/01/26 Due: 09/01/27

CGA-TAVI Registry to Evaluate the Predictive Value of a CGA in Predicting TAVI Outcomes

Phase: N/A Priority: Normal
NCT ID: NCT01991444 Org: User:
Start: 02/28/14 End: 02/28/17 Due: 02/28/18

Study to Improve Outcomes in Aortic Stenosis

Phase: N/A Priority: Normal
NCT ID: NCT03112629 Org: User:
Start: 03/23/17 End: 04/03/19 Due: 04/03/20

The EASE-IT CT Registry

Phase: N/A Priority: Normal
NCT ID: NCT05750173 Org: User:
Start: 09/01/23 End: 08/31/25 Due: 08/31/26

Inspiris Resilia Durability Registry

Phase: N/A Priority: Normal
NCT ID: NCT03666741 Org: User:
Start: 04/26/19 End: 07/31/26 Due: 07/31/27

Cardioprotective Effect of RIPC in Patients Undergoing TAVI

Phase: N/A Priority: Normal
NCT ID: NCT02283398 Org: User:
Start: 11/30/14 End: 04/30/16 Due: 04/30/17

The DefiPace Study

Phase: N/A Priority: Normal
NCT ID: NCT04804748 Org: User:
Start: 03/28/23 End: 08/31/26 Due: 08/31/27

SAVR: IMPACT of Pre-existing Comorbidities on Patient Outcomes and Prosthetic Valve Performance in a Real-world Setting.

Phase: N/A Priority: Normal
NCT ID: NCT04053088 Org: User:
Start: 12/12/19 End: 08/01/26 Due: 08/01/27